Calcium Acetate Capsules — Class III drug recall D-0473-2018
Terminated recall by Nostrum Laboratories Inc, reported 2018-02-28, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0473-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Nostrum Laboratories Inc, Kansas City, MO, United States |
| Recall initiated | 2018-02-13 |
| Classified | 2018-02-20 |
| Reported by FDA | 2018-02-28 |
| Terminated | 2018-12-13 |
| Distributed | Nationwide (US) |
| Quantity | 1,439,000 oral |
| NDC | 29033-0026-02 |
| Lot numbers | 09/19, CAL173502 |
Product
Calcium Acetate Capsules, 667 mg, 200 Capsules per bottle, Rx Only. Manufactured by Nostrum Laboratories, Inc. Kansas City, MO 64120. NDC 29033-026-02
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0473-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.